Abstract
Onwah O, Nwanja E, Akpan U, et al. Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in Southern Nigeria. Ther Adv Infect Dis 2024; 11. doi:10.1177/20499361241242240
In this article, there were errors in the “Abstract” and “Results” section concerning the adjusted odds ratio (aOR) for the association between ART duration and pLLV and in Table 3 “Duration on ART” value, which has now been corrected.
The errors and their corresponding correction descriptions are given below:
In the Result subsection of Abstract section, incorrect sentence “Increasing ART duration [adjusted odds ratio (aOR) = 1.0; 95% confidence interval (CI): 1.005–1.008; p < 0.001]” has been corrected to “Increasing ART duration [adjusted odds ratio (aOR) = 1.9 [95% CI: 1.54–2.44, p < 0.001]”.
In Results section, incorrect sentence “In multivariate analysis, increasing duration of ART [adjusted odds ratio (aOR) = 1.0; 95% CI: 1.005–1.008; p < 0.001]” has been corrected to “In multivariate analysis, increasing duration of ART [adjusted odds ratio (aOR) = 1.9 [95% CI: 1.54–2.44, p < 0.001]”
In Table 3, Duration on ART value was misplaced and reported for ART duration ⩽12 months, with ART duration >12 months as the reference category. The correct labeling is as follows:
